Aurora Spine Corp (ASG) - Cash Flow Conversion Efficiency

Latest as of June 2026: -0.062x

Based on the latest financial reports, Aurora Spine Corp (ASG) has a cash flow conversion efficiency ratio of -0.062x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-175.59K ≈ $-127.02K USD) by net assets (CA$2.83 Million ≈ $2.04 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see ASG market cap for the company's overall valuation and market capitalisation.

Aurora Spine Corp - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Aurora Spine Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Aurora Spine Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Aurora Spine Corp ranked by their cash flow conversion efficiency. Explore ASG cash flow quality index to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
NORDIC TECH.GRP.NK-00423
F:UA5
N/A
Barramundi Group Ltd
OL:BARRA
0.044x
Siren Gold Ltd
AU:SNG
-0.050x
Alliance Developpement Capital SIIC SE
PA:ALDV
0.009x
Cambridge Technology Enterprises Limited
NSE:CTE
0.319x
MMC Sanayi ve Ticari Yatirimlar AS
IS:MMCAS
0.001x
La Rosa Holdings Corp. Common Stock
NASDAQ:LRHC
0.116x
Korporacja Gospodarcza efekt S.A
WAR:EFK
-0.094x

Annual Cash Flow Conversion Efficiency for Aurora Spine Corp (2012–2025)

The table below shows the annual cash flow conversion efficiency of Aurora Spine Corp from 2012 to 2025. View Aurora Spine Corp share price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CA$3.81 Million
≈ $2.76 Million
CA$917.37K
≈ $663.61K
0.241x +0.01%
2024-12-31 CA$4.40 Million
≈ $3.18 Million
CA$1.06 Million
≈ $765.25K
0.241x +236.29%
2023-12-31 CA$5.30 Million
≈ $3.83 Million
CA$-935.06K
≈ $-676.41K
-0.177x +51.08%
2022-12-31 CA$4.32 Million
≈ $3.12 Million
CA$-1.56 Million
≈ $-1.13 Million
-0.361x +5.62%
2021-12-31 CA$5.57 Million
≈ $4.03 Million
CA$-2.13 Million
≈ $-1.54 Million
-0.382x -505.26%
2020-12-31 CA$3.28 Million
≈ $2.37 Million
CA$309.57K
≈ $223.94K
0.094x +22780.75%
2019-12-31 CA$1.77 Million
≈ $1.28 Million
CA$729.00
≈ $527.35
0.000x -99.72%
2018-12-31 CA$2.96 Million
≈ $2.14 Million
CA$435.79K
≈ $315.24K
0.147x +121.24%
2017-12-31 CA$1.65 Million
≈ $1.19 Million
CA$-1.15 Million
≈ $-828.63K
-0.694x -41.82%
2016-12-31 CA$3.47 Million
≈ $2.51 Million
CA$-1.70 Million
≈ $-1.23 Million
-0.489x +34.12%
2015-12-31 CA$4.69 Million
≈ $3.39 Million
CA$-3.48 Million
≈ $-2.52 Million
-0.742x +63.57%
2014-12-31 CA$3.50 Million
≈ $2.53 Million
CA$-7.13 Million
≈ $-5.16 Million
-2.038x +6.72%
2013-12-31 CA$1.44 Million
≈ $1.04 Million
CA$-3.15 Million
≈ $-2.28 Million
-2.184x +73.39%
2012-12-31 CA$158.51K
≈ $114.66K
CA$-1.30 Million
≈ $-941.41K
-8.210x --

About Aurora Spine Corp

V:ASG Canada Medical Devices
Market Cap
$8.47 Million
CA$11.71 Million CAD
Market Cap Rank
#27565 Global
#1172 in Canada
Share Price
CA$0.15
Change (1 day)
+3.45%
52-Week Range
CA$0.15 - CA$0.33
All Time High
CA$0.91
About

Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., engages in the development and distribution of minimally invasive interspinous fusion systems and devices in Canada. The company offers interspinous process lumbar fusion devices, such as the ZIP, ZIP ULTR, ZIP LP, and ZIP-51 for patients suffering from degenerative disc diseases. It also provides SOLO, an anterior lumbar inter… Read more